Multinational clinical trials offer foreign pharmaceutical companies the opportunity to bring innovative treatments to a broader patient population. However, expanding the research footprint also brings the complex requirement of complying with diverse international regulations.
In the rapidly evolving landscape of Turkish healthcare regulations, distinguishing between a "medical device" and a "general use product" is critical for manufacturers and importers. TITCK recently published a vital announcement regarding products that do not fall within the scope of the MDR and IVDR.
